Efficacy and safety of ustekinumab in a group of 22 elderly patients with psoriasis over a 2-year period

Clin Exp Dermatol. 2016 Jul;41(5):564-6. doi: 10.1111/ced.12850. Epub 2016 Mar 30.
No abstract available

Publication types

  • Letter

MeSH terms

  • Aged
  • Dermatologic Agents / adverse effects
  • Dermatologic Agents / therapeutic use*
  • Female
  • Humans
  • Male
  • Psoriasis / drug therapy*
  • Retrospective Studies
  • Severity of Illness Index
  • Ustekinumab / adverse effects
  • Ustekinumab / therapeutic use*

Substances

  • Dermatologic Agents
  • Ustekinumab